Retraction Note: Polymerase θ inhibition activates the cGAS-STING pathway and cooperates with immune checkpoint blockade in models of BRCA-deficient cancer

• Jeffrey Patterson-Fortin,
• Heta Jadhav,
• Constantia Pantelidou,
• Tin Phan,
• Carter Grochala,
• Anita K. Mehta,
• Jennifer L. Guerriero,
• Gerburg M. Wulf,
• Brian M. Wolpin,
• Ben Z. Stanger,
• Andrew J. Aguirre,
• James M. Cleary,
• Alan D. D’Andrea,
• Geoffrey I. Shapiro

Affiliations

Jeffrey Patterson-Fortin

Department of Medical Oncology, Dana-Farber Cancer Institute

Heta Jadhav

Department of Medical Oncology, Dana-Farber Cancer Institute

Constantia Pantelidou

Department of Medical Oncology, Dana-Farber Cancer Institute

Tin Phan

Department of Radiation Oncology, Dana-Farber Cancer Institute and Harvard Medical School

Carter Grochala

Department of Radiation Oncology, Dana-Farber Cancer Institute and Harvard Medical School

Anita K. Mehta

Department of Surgical Oncology and Harvard Medical School, Brigham and Women’s Hospital

Jennifer L. Guerriero

Department of Surgical Oncology and Harvard Medical School, Brigham and Women’s Hospital

Gerburg M. Wulf

Department of Medicine, Division of Hematology-Oncology, Beth Israel Deaconess Medical Center and Harvard Medical School

Brian M. Wolpin

Department of Medical Oncology, Dana-Farber Cancer Institute

Ben Z. Stanger

Department of Medicine, Division of Gastroenterology, Abramson Family Cancer Research Institute, University of Pennsylvania Perelman School of Medicine

Andrew J. Aguirre

Department of Medical Oncology, Dana-Farber Cancer Institute

James M. Cleary

Department of Medical Oncology, Dana-Farber Cancer Institute

Alan D. D’Andrea

Department of Radiation Oncology, Dana-Farber Cancer Institute and Harvard Medical School

Geoffrey I. Shapiro

Department of Medical Oncology, Dana-Farber Cancer Institute